BiotechTube
Home/Veroscience/Anthony H. Cincotta, PhD
AH

Anthony H. Cincotta, PhD

President and Chief Science Officer

Veroscience

Therapeutic Areas

Metabolic DiseasesImmunological DisordersOncology

Veroscience Pipeline

DrugIndicationPhase
CyclosetType 2 DiabetesApproved
VS41157Pancreatic CancerPreclinical/Clinical
CNRT-based TherapiesImmunological DisordersResearch